ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review

Xing, Na; Long, Xiao-Tong; Zhang, Hui-Juan; Fu, Li-Dan; Huang, Jian-Yuan; Chaurembo, Abdallah Iddy; Chanda, Francis; Xu, Yun-Jing; Shu, Chi; Lin, Kai-Xuan; Yang, Ke*; Lin, Han-Bin*广州中医药大学; 南方医科大学; 中国科学院研究生院; 中国科学院
Frontiers in Pharmacology2022-12-6DOI: 10.3389/fphar.2022.1055248
1被引13阅读
引用收藏
分享

摘要

Ischemic heart disease (IHD) is a high-risk disease in the middle-aged and elderly population. The ischemic heart may be further damaged after reperfusion therapy with percutaneous coronary intervention (PCI) and other methods, namely, myocardial ischemia-reperfusion injury (MIRI), which further affects revascularization and hinders patient rehabilitation. Therefore, the investigation of new therapies against MIRI has drawn great global attention. Within the long history of the prevention and treatment of MIRI, traditional Chinese medicine (TCM) has increasingly been recognized by the scientific community for its multi-component and multi-target effects. These multi-target effects provide a conspicuous advantage to the anti-MIRI of TCM to overcome the shortcomings of single-component drugs, thereby pointing toward a novel avenue for the treatment of MIRI. However, very few reviews have summarized the currently available anti-MIRI of TCM. Therefore, a systematic data mining of TCM for protecting against MIRI will certainly accelerate the processes of drug discovery and help to identify safe candidates with synergistic formulations. The present review aims to describe TCM-based research in MIRI treatment through electronic retrieval of articles, patents, and ethnopharmacology documents. This review reported the progress of research on the active ingredients, efficacy, and underlying mechanism of anti-MIRI in TCM and TCM formulas, provided scientific support to the clinical use of TCM in the treatment of MIRI, and revealed the corresponding clinical significance and development prospects of TCM in treating MIRI.

学科与关键词

关键词
myocardial ischemia-reperfusion injurypathogenesistraditional Chinese medicinecardioprotective effectsmolecular mechanisms
相关
加载中…
  • Research Progress on The Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury
    Zhang, Dong; Wu, Hui*; Liu, Di; Li, Yun Zhao; Zhou, GangHEART SURGERY FORUM, 2022, 25(3): E462-E468.被引 5
  • Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine
    Yang, Hua-Yi; Liu, Mengnan; Luo, Pei*; Yao, Xin-Sheng*; Zhou, Hua*PHYTOMEDICINE, 2022, 104: 154268.被引 24
  • Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway
    Cao, Ce; Qi, Yu-tong; Wang, Ao-ao; Wang, Zi-yan; Liu, Zi-xin; Meng, Hong-xu; Li, Lei; Liu, Jian-xun*Chinese Journal of Integrative Medicine, 2023, 29(12): 1066-1076.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-12-06
卷期
第 13 卷
页码
1055248
DOI
10.3389/fphar.2022.1055248
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; High-level New R&D Institute of Department of Science and Technology of Guangdong Province; High-level Innovative Research Institute of Department of Science and Technology of Guangdong Province; [82100391]; [2019B090904008]; [2021B0909050003]

作者

  • X

    Xing, Na (第一作者)

    chinese acad sci · shanghai inst mat med · cas

  • L

    Long, Xiao-Tong

    cas

查看全部 12 位作者收起作者
  • Z

    Zhang, Hui-Juan

    cas

  • F

    Fu, Li-Dan

    cas

  • H

    Huang, Jian-Yuan

    southern med univ · cas

  • C

    Chaurembo, Abdallah Iddy

    univ chinese acad sci · chinese acad sci · shanghai inst mat med · cas

  • C

    Chanda, Francis

    univ chinese acad sci · cas · chinese acad sci · shanghai inst mat med

  • X

    Xu, Yun-Jing

    univ chinese acad sci · chinese acad sci · shanghai inst mat med · cas

  • S

    Shu, Chi

    shenyang agr univ · cas

  • L

    Lin, Kai-Xuan

    guangzhou univ chinese med

  • Y

    Yang, Ke (通讯)

    china jiliang univ · cas

  • L

    Lin, Han-Bin (通讯)

    chinese acad sci · shanghai inst mat med · univ chinese acad sci · cas

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417